Market Movers

NRG Energy, Inc. (NRG)

80.27 USD -3.33 (-3.98%) Volume: 2.89M

NRG Energy, Inc.’s stock price stands at 80.27 USD, experiencing a dip of -3.98% this trading session with a trading volume of 2.89M, yet showcasing a robust year-to-date increase of +55.26%, reflecting its dynamic market performance.

Latest developments on NRG Energy, Inc.

Today, Nrg Energy Inc stock price movements were influenced by various key events. Allspring Global Investments Holdings LLC recently acquired 148,509 shares of NRG Energy, Inc., indicating a bullish sentiment towards the company. Additionally, Highland Capital Management LLC disclosed a significant $4.32 million stock position in NRG Energy, Inc., further boosting investor confidence. However, State of Michigan Retirement System decided to reduce its holdings in NRG Energy, Inc., potentially impacting the stock price. Overall, analysts suggest that NRG Energy, Inc. remains a darkhorse AI energy play, offering potential opportunities for investors.

NRG Energy, Inc. on Smartkarma

According to Baptista Research on Smartkarma, Nrg Energy Inc has been highlighted as a key growth catalyst with the expansion of its Smart Home and Consumer Energy Platforms. The company’s strong start to 2024, exceeding expectations, and transformative trends in power demand have positioned NRG Energy Inc favorably in the power sector. With a diversified generation portfolio and consumer technology platform, NRG is strategically poised to benefit from tightening supply and demand dynamics in key markets.

A look at NRG Energy, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

NRG Energy Inc, a company that owns and operates power-generating facilities in the United States, has been rated using the Smartkarma Smart Scores. The overall outlook for NRG Energy Inc indicates a positive long-term growth potential, with a high score in the Growth category. This suggests that the company is expected to expand and increase its market presence in the future.

Although NRG Energy Inc has received a moderate score in Value, Dividend, Resilience, and Momentum, the strong score in Growth indicates promising prospects for the company’s future development. With a diverse portfolio of energy production facilities, NRG Energy Inc is positioned to capitalize on opportunities in the evolving energy market and maintain its competitive edge in the industry.

### NRG Energy, Inc. owns and operates a diverse portfolio of power-generating facilities, primarily in the United States. The Company’s operations include energy production and cogeneration facilities, thermal energy production, and energy resource recovery facilities. ###

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

The J. M. Smucker Company (SJM)

114.73 USD -5.97 (-4.95%) Volume: 3.06M

The J. M. Smucker Company’s stock price stands at 114.73 USD, witnessing a drop of -4.95% in the recent trading session with a trading volume of 3.06M. The stock has also experienced a downturn with a year-to-date (YTD) percentage change of -9.22%, reflecting its volatile performance in the market.

Latest developments on The J. M. Smucker Company

The J.M. Smucker Co. recently announced its fiscal 2025 first-quarter results, with adjusted EPS of $2.44 beating estimates and net sales reaching $2.1 billion. However, the company’s stock price dipped following a cut in its fiscal full-year guidance. CEO cited cost-weary shoppers and tightened purses as reasons for the guidance cut, as consumers tighten discretionary spending due to inflation. Despite beating profit estimates, Smucker lowered its full-year earnings view, leading to a decrease in stock value. The company’s sales were down $41.3 million in Q1 FY25, even as profits increased. J.M. Smucker Co. is facing challenges in the market as it adjusts its outlook to reflect changing consumer behavior and economic conditions.

The J. M. Smucker Company on Smartkarma

Analysts at Baptista Research have provided insightful coverage on Jm Smucker Co on Smartkarma. In their report titled “The J. M. Smucker Company: These Are The 4 Fundamental Factors Driving Its Performance! – Financial Forecasts,” they highlighted the company’s mixed operational and financial stance in its Fiscal 2024 Fourth Quarter. The management’s cautious approach towards scaling operations and navigating market volatilities, especially in the coffee segment, was emphasized. Baptista Research aims to evaluate various factors influencing the company’s price in the near future and conduct an independent valuation using a Discounted Cash Flow (DCF) methodology.

In another report by Baptista Research titled “The J. M. Smucker Company: Initiation Of Coverage – Core Business Strategy & 5 Key Performance Drivers – Financial Forecasts,” analysts provided their first coverage on the food and beverage major, J. M. Smucker. They highlighted promising growth indicators in the company’s 3rd quarter earnings for fiscal year 2024, validating strategic product mix maneuvers and expressing confidence in forecasting. Company executives showed marginal optimism, with a reported 6% comparable sales growth. The analysts’ coverage on Smartkarma offers valuable insights for investors interested in Jm Smucker Co.

A look at The J. M. Smucker Company Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Jm Smucker Co has a positive long-term outlook. With high scores in Dividend and Value, the company is seen as a strong investment option for those looking for stable returns. Additionally, its Momentum score indicates that the company is showing positive growth potential in the market.

Jm Smucker Co‘s lower scores in Growth and Resilience suggest that there may be some challenges ahead in terms of expanding their product lines and weathering economic downturns. However, with a solid foundation in producing a wide range of food products, including peanut butter, fruit spreads, and baking ingredients, the company is well-positioned to maintain its market presence and continue to provide value to shareholders.

### The JM Smucker Company manufactures and markets food products on a worldwide basis. The Company’s principal products include peanut butter, shortening and oils, fruit spreads, canned milk, baking mixes and ready-to-spread frostings, flour and baking ingredients, juices and beverages, frozen sandwiches, dessert toppings, syrups, pickles and condiments, and potato side dishes. ###

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Super Micro Computer, Inc. (SMCI)

443.49 USD -104.15 (-19.02%) Volume: 36.6M

Super Micro Computer, Inc.’s stock price is currently at 443.49 USD, experiencing a significant drop of 19.02% this trading session. Despite the significant volume of 36.6M shares traded, the company’s stock performance remains positive with a 56.02% increase YTD, showcasing its resilience in the market.

Latest developments on Super Micro Computer, Inc.

Super Micro Computer stock has taken a hit as the company delays its annual report following a report from a short-seller, causing shares to plummet by 25%. The delay in filing the 10-K report has led to accusations of accounting irregularities and manipulation, sparking concerns among investors. The postponement of the filing comes in the wake of a scathing report from Hindenburg Research, which raised red flags about the company’s financial practices. As a result, Super Micro Computer stock has tanked by over 20%, leaving investors wary of the company’s future performance.

Super Micro Computer, Inc. on Smartkarma

Independent analysts on Smartkarma have been covering Super Micro Computer, Inc. with a bullish sentiment. Baptista Research highlighted the company’s strong financial performance in Q4 2024, reporting a record revenue growth of 143% year-over-year to $5.31 billion. The company’s focus on AI server and data center infrastructure solutions, as well as its transition to direct liquid cooling technology, have positioned it as a key player in the evolving technology landscape.

Another analyst, Uttkarsh Kohli, discussed Super Micro Computer‘s inclusion in the NASDAQ-100 index, replacing Walgreens. With a surge of 214% year-to-date and strategic partnerships with Nvidia and AMD, SMCI is expected to outperform. In contrast, Walgreens has declined 56% year-to-date and failed to maintain its market value for index inclusion. Historically, stocks added to indices have shown brief outperformance, and both SMCI and WBA have displayed strong trends due to unique factors.

A look at Super Micro Computer, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Super Micro Computer, Inc. is looking at a positive long-term outlook based on the Smartkarma Smart Scores. With high scores in Growth and Momentum, the company is positioned for future success and expansion. The company’s focus on developing server solutions based on modular and open-standard x86 architecture is likely to drive growth and innovation in the industry.

Although Super Micro Computer scores lower in Value and Dividend, its strong scores in Growth and Momentum indicate a promising future. The company’s resilience score also suggests that it is well-equipped to handle challenges and navigate market changes effectively. Overall, Super Micro Computer‘s strategic focus on server solutions and strong performance in key areas bodes well for its long-term prospects in the industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

M&T Bank Corporation (MTB)

170.43 USD +3.03 (+1.81%) Volume: 1.01M

M&T Bank Corporation’s stock price soared to 170.43 USD, marking a significant trading session increase of +1.81% with a robust trading volume of 1.01M. YTD performance also shows a promising trend with a +24.33% surge, highlighting MTB’s strong market position and growth potential.

Latest developments on M&T Bank Corporation

Today, M&T Bank Corp. (MTB) stock is making headlines as it continues to rise, despite still underperforming the market. Analysts at Morgan Stanley have shown strong confidence in the company, listing it among their highest conviction stocks. Meanwhile, Raymond James & Associates recently sold off a significant number of shares in M&T Bank Corp. (NYSE:MTB). Investors are closely watching as they decode the strategic SWOT insights of the company to better understand its stock price movements.

A look at M&T Bank Corporation Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, M & T Bank Corp has a positive long-term outlook. The company scores well in value, growth, and momentum, indicating strong performance in these areas. With a focus on providing commercial banking, trust, and investment services, M & T Bank Corp is well-positioned to continue its growth and resilience in the market.

Despite a slightly lower score in dividends and resilience, M & T Bank Corp‘s overall outlook remains favorable. The company’s presence in various states along the East Coast provides a solid foundation for continued success. Investors may find M & T Bank Corp to be a promising investment opportunity based on its strong performance across multiple factors.

Summary: M&T Bank Corporation is a bank holding company that offers commercial banking, trust, and investment services through its branch offices in several states along the East Coast.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Bristol-Myers Squibb Company (BMY)

49.06 USD +0.94 (+1.95%) Volume: 8.39M

Bristol-Myers Squibb Company’s stock price stands at 49.06 USD, marking a positive trading session with a 1.95% increase and a trading volume of 8.39M. However, the percentage change YTD indicates a slight dip of -4.39%, showcasing a mixed performance in the market.

Latest developments on Bristol-Myers Squibb Company

Today, Bristol-Myers Squibb’s stock price saw a positive movement following an analyst upgrade, with shares trading 2.7% higher. The company is gearing up to participate in upcoming investor conferences and present data across its cardiovascular portfolio at the European Society of Cardiology Congress 2024. Regulators are expected to approve an innovative schizophrenia treatment from Bristol Myers, while disappointing data from Neurocrine Biosciences has impacted investor sentiment. Market whales have shown interest in BMY options, and Jefferies Financial Group has set a new price target of $51.00 for the company’s stock. Despite recent challenges, Bristol Myers Squibb could be on the mend as it continues to make strategic moves in the healthcare sector.

A look at Bristol-Myers Squibb Company Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Bristol-Myers Squibb has a promising long-term outlook. With a high score of 5 for Dividend, investors can expect a steady stream of income from the company. Additionally, the company scored a 4 in Momentum, indicating strong positive price momentum. However, Bristol-Myers Squibb scored lower in Resilience with a 2, suggesting potential vulnerability to market fluctuations. Overall, the company scored a 3 for Value and Growth, showing moderate potential for growth and a fair valuation.

Bristol-Myers Squibb Company is a global biopharmaceutical company that focuses on developing and selling pharmaceutical and nutritional products. Their products and therapies target a wide range of health issues including cancer, heart disease, HIV and AIDS, diabetes, and psychiatric disorders. With a strong Dividend score of 5 and promising Momentum of 4, Bristol-Myers Squibb appears to be well-positioned for long-term success, despite scoring lower in Resilience. Investors may find the company’s stock appealing for its potential income and growth opportunities.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Gilead Sciences, Inc. (GILD)

78.56 USD +1.56 (+2.03%) Volume: 6.2M

Gilead Sciences, Inc.’s stock price is currently at 78.56 USD, marking a positive percentage change of +2.03% in this trading session, with a substantial trading volume of 6.2M. Despite this, the YTD percentage change is still at -3.02%, reflecting the volatile market conditions.

Latest developments on Gilead Sciences, Inc.

Gilead Sciences Inc. stock rose by 2.5% on Tuesday, continuing its upward trend for the seventh straight session. Despite this increase, the stock is still underperforming compared to the overall market. The rise in stock price comes amidst the release of “The Adventure Jar,” a heartwarming story showcasing a family navigating the challenges of a cancer diagnosis and finding magic in spending time together. This emotional narrative may have resonated with investors, contributing to the positive movement in Gilead Sciences’ stock today.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Tyson Foods, Inc. (TSN)

65.69 USD +1.76 (+2.75%) Volume: 3.04M

With a significant surge of +2.75% this trading session, Tyson Foods, Inc.’s stock price has reached 65.69 USD. The trading volume stands at 3.04M, highlighting the stock’s popularity among investors. Moreover, the impressive year-to-date percentage change of +22.21% underscores Tyson Foods, Inc.’s robust performance in the market.

Latest developments on Tyson Foods, Inc.

Tyson Foods Inc Cl A stock price experienced significant movements today following a series of key events. The company reported strong quarterly earnings, exceeding expectations and driving investor confidence. Additionally, Tyson Foods Inc Cl A announced a new partnership with a major retailer, expanding its market reach and boosting revenue projections. However, concerns over rising commodity prices and supply chain disruptions have also impacted the stock price. Overall, market analysts are closely monitoring Tyson Foods Inc Cl A as it navigates through these challenges and opportunities in the current economic landscape.

Tyson Foods, Inc. on Smartkarma

Analysts at Baptista Research on Smartkarma are bullish on Tyson Foods Inc Cl A, highlighting the company’s strong performance in the fiscal third quarter of 2024. According to their research report titled “Tyson Foods: Expansion in Prepared Foods Sector & Leveraging International Growth Opportunities To Catalyze The Top-Line! – Major Drivers,” Tyson Foods saw a substantial increase in adjusted operating income and adjusted earnings per share, marking the highest profitability observed in the last 7 quarters.

Another report by Baptista Research on Smartkarma, titled “Tyson Foods: Is The Improved Live Performance and Supply-Demand Balance Here To Stay? – Major Drivers,” also paints a positive picture for Tyson Foods. The analysts note the company’s robust performance in the fiscal second quarter of 2024, crediting it to operational efficiencies and a diversified portfolio. Despite facing challenges in different segments, analysts remain optimistic about Tyson Foods’ future prospects.

A look at Tyson Foods, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Tyson Foods Inc Cl A has a positive long-term outlook. With high scores in Dividend and Momentum, the company shows strong potential for growth and stability. Additionally, its Value score indicates that it may be undervalued in the market, presenting a good opportunity for investors. While the Growth and Resilience scores are not as high, the overall outlook for Tyson Foods Inc Cl A appears promising.

Tyson Foods, Inc. is a company that produces and distributes a variety of food products, including chicken, beef, pork, and prepared foods. With a focus on selling to a wide range of retailers and distributors, the company has established a strong presence in the market. The high Dividend and Momentum scores suggest that Tyson Foods Inc Cl A is well-positioned for future success, making it a potentially attractive investment option for those looking for stable returns and growth potential.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Insulet Corporation (PODD)

204.42 USD +11.84 (+6.15%) Volume: 1.27M

Insulet Corporation’s stock price soared to $204.42, marking a significant trading session increase of +6.15%, with a robust trading volume of 1.27M. Despite the current uptick, the stock has seen a year-to-date decrease of -5.79%, shedding light on its volatile performance.

Latest developments on Insulet Corporation

Insulet Corp‘s stock price saw a 3.6% increase today following the FDA approval of its Omnipod 5 Automated Insulin Delivery System for Type 2 Diabetes. This clearance has garnered positive ratings from analysts, with Oppenheimer maintaining an Outperform rating and Piper Sandler reiterating an Overweight tag on Insulet’s stock. Jefferies also continues to support the company with a Buy tag and consistent target. Additionally, Raymond James & Associates reduced their holdings in Insulet Co., while the stock price gapped up to $180.69. The market seems bullish on Insulet as the FDA nod for their insulin delivery system for type 2 diabetes patients propels the company forward.

Insulet Corporation on Smartkarma

Analysts at Baptista Research have been closely monitoring Insulet Corp‘s performance, particularly focusing on the company’s innovative edge in the insulin pump market. The latest reports indicate that Insulet Corporation reported an excellent first quarter of 2024, exceeding expectations with the continued rise in demand for Omnipod 5. This leading insulin delivery system has fueled robust revenue growth for the company, with an overall Omnipod revenue growth of 21%. Baptista Research‘s report evaluates various factors influencing the company’s price in the near future, including carrying out a fundamental analysis and a Discounted Cash Flow (DCF) valuation to provide investors with a comprehensive understanding of the risks and opportunities.

In another report by Baptista Research, the analysts delve into Insulet Corporation’s strategy of connecting with healthcare professionals for penetration in niche markets. The company’s strong Q4 2023 results, marking its eighth consecutive year of 20-plus percent revenue growth, showcase the success of this strategy. The automated insulin delivery system, Omnipod 5, has been a key driver of financial success for Insulet Corp, generating $1 billion in revenue in 2023. With approximately 425,000 global customers using the Omnipod platform, representing a 25% growth from the previous year, Insulet Corp‘s strategic approach seems to be working effectively in expanding its market presence.

A look at Insulet Corporation Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Insulet Corp, a medical device company specializing in insulin infusion systems for diabetes patients, shows a promising long-term outlook based on its Smartkarma Smart Scores. With a high score of 5 in Growth, the company is positioned for significant expansion and development in the future. This indicates a strong potential for Insulet Corp to increase its market presence and revenue streams over time.

While Insulet Corp scores lower in other areas such as Value and Dividend, its overall outlook remains positive with a balanced combination of scores across different factors. With a solid score of 3 in Momentum, the company is likely to maintain its current growth trajectory and market performance. Additionally, its focus on resilience with a score of 2 suggests that Insulet Corp is well-prepared to navigate challenges and maintain its position in the medical device industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Biggest stock gainers today in S&P 500

Biggest stock losers today in S&P 500

What is Smartkarma SmartScore?

It is a compound score for a Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores (Value, Dividend, Growth, Resilience, Momentum scores) computed by Smartkarma.

The best stock screener – Smartkarma SmartScore Screener

Smartkarma’s stock screener, Smartkarma SmartScore Screener, allows you to easily discover undervalued gems, high dividend stocks, and high growth stocks, across multiple countries and sectors.

Explore the Smartkarma SmartScore Screener now.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Bio-Rad Laboratories, Inc. (BIO)

328.75 USD +9.38 (+2.94%) Volume: 0.24M

Bio-Rad Laboratories, Inc.’s stock price is currently soaring at 328.75 USD, marking a significant trading session increase of +2.94%. With a trading volume of 0.24M and a year-to-date percentage change of +1.81%, BIO’s stock performance is making positive strides in the market.

Latest developments on Bio-Rad Laboratories, Inc.

Today, Bio-Rad Laboratories, Inc. saw fluctuations in its stock price following the release of its Q3 2024 earnings forecast of $2.14 per share by Zacks Research. Analysts at Wells Fargo & Company gave the company an equal weight rating, further impacting investor sentiment. The FY2024 earnings forecast for Bio-Rad Laboratories, Inc. was also issued by Zacks Research, adding to the mix of factors influencing the stock price movements today on the NYSE under the ticker symbol BIO.

Bio-Rad Laboratories, Inc. on Smartkarma

Analysts at Baptista Research have provided bullish coverage of Bio-Rad Laboratories A on Smartkarma. In their report titled “Bio-Rad Laboratories: A Strengthened Position in Digital PCR (ddPCR) and Diagnostics With Solid Presence In China! – Major Drivers,” they highlighted the company’s second-quarter performance in 2024. CEO Norman Schwartz noted that the quarter met revenue expectations and showed better-than-expected margin performance. Despite facing challenges in the biotech and biopharma sectors, the company revised its full-year 2024 financial outlook cautiously.

In another report by Baptista Research on Smartkarma titled “Bio-Rad Laboratories Inc.: Exciting New Product Launches Can Propel Their Revenue Growth? – Major Drivers,” analysts discussed the multinational firm’s first-quarter 2024 financial results. The report noted that the company’s performance fluctuations were influenced by macroeconomic and market trends in the biotech and biopharma segments, particularly in countries like China and Russia. Despite observing a decline in the Life Science Group, the results were in line with internal estimates.

A look at Bio-Rad Laboratories, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Bio-Rad Laboratories A has a positive long-term outlook. With high scores in value and momentum, the company is positioned well for growth and profitability. The company’s products and systems are designed to separate and analyze complex materials, which could lead to continued success in the life science research and clinical diagnostics industries.

Although Bio-Rad Laboratories A has a lower score in dividends and growth, its resilience score indicates that the company is able to withstand economic challenges and market fluctuations. Overall, Bio-Rad Laboratories A appears to be a strong player in the industry with a solid foundation for future success.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma